0 NASDAQ Companies - November 14, 2018Eidos Therapeutics to Present at Two Upcoming Investor ConferencesSAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a […]Read More
0 NASDAQ Companies - November 14, 2018Xcel Brands, Inc. Announces Third Quarter 2018 Financial ResultsCompany Reports Third Quarter Total Revenues of $8.3 Million; +5 % from Prior Year Quarter Third Quarter Operating Income of […]Read More
0 NASDAQ Companies - November 14, 2018MagneGas Provides Business Update for the Third Quarter of 2018More than 195% Quarterly Revenue Increase from Last Year TAMPA, Fla., Nov. 14, 2018 (GLOBE NEWSWIRE) — MagneGas Applied Technology […]Read More
0 NASDAQ Companies - November 14, 2018RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR SymposiumTEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) […]Read More
0 NASDAQ Companies - November 14, 2018Titan Machinery Inc. to Report Fiscal Third Quarter Ended October 31, 2018 Results on November 29, 2018WEST FARGO, N.D., Nov. 14, 2018 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN) announced today it will release financial […]Read More
0 NASDAQ Companies - November 14, 2018Micron Unveils Secure NOR Flash Memory Solution to Accelerate and Authenticate Intelligence at the EdgeNew Micron MT25Q NOR Flash Enabled with Authenta™ Technology Embeds Cyber Security into Standard Flash Memory, Reducing Costs and Time to […]Read More
0 NASDAQ Companies - November 14, 2018Vera Bradley Foundation for Breast Cancer Raises $2.2 million for Breast Cancer ResearchFORT WAYNE, Ind., Nov. 14, 2018 (GLOBE NEWSWIRE) — The Vera Bradley Foundation for Breast Cancer (the “Foundation”) recently announced […]Read More
0 NASDAQ Companies - November 14, 2018Replimune Reports Financial Results for the Second Fiscal Quarter, Ended September 30, and Provides Development and Corporate UpdateU.S. Clinical Sites for Phase 1/2 Trial of RP1 in Patients with Solid Tumors on Track to Initiate by End […]Read More
0 NASDAQ Companies - November 14, 2018Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business UpdateCompleted $75.0 million initial public offering in September Reported positive Phase 2 topline results of lead program ETX2514SUL On-track to […]Read More
0 NASDAQ Companies - November 14, 2018Cue Biopharma to Host Business Update Call and WebcastCAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) — Cue Biopharma, Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, […]Read More